News

Zacks Investment Research on MSN2h
GSK Stock Rises Almost 22% in 6 Months: Time to Buy, Sell or Hold?
GSK GSK stock has risen 21.5% in the past six months. The consistently strong performance of the Specialty Medicines unit, ...
Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards?
Merck's Gardasil sales decline due to weak demand trends in China, with new launches expected to offset the downside.